1. Home
  2. VERV vs NNOX Comparison

VERV vs NNOX Comparison

Compare VERV & NNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERV
  • NNOX
  • Stock Information
  • Founded
  • VERV 2018
  • NNOX N/A
  • Country
  • VERV United States
  • NNOX Israel
  • Employees
  • VERV N/A
  • NNOX N/A
  • Industry
  • VERV Medicinal Chemicals and Botanical Products
  • NNOX Medical Electronics
  • Sector
  • VERV Health Care
  • NNOX Health Care
  • Exchange
  • VERV Nasdaq
  • NNOX Nasdaq
  • Market Cap
  • VERV 382.5M
  • NNOX 358.0M
  • IPO Year
  • VERV 2021
  • NNOX 2020
  • Fundamental
  • Price
  • VERV $4.79
  • NNOX $5.85
  • Analyst Decision
  • VERV Strong Buy
  • NNOX Buy
  • Analyst Count
  • VERV 4
  • NNOX 1
  • Target Price
  • VERV $25.75
  • NNOX $14.00
  • AVG Volume (30 Days)
  • VERV 1.4M
  • NNOX 1.1M
  • Earning Date
  • VERV 11-05-2024
  • NNOX 11-21-2024
  • Dividend Yield
  • VERV N/A
  • NNOX N/A
  • EPS Growth
  • VERV N/A
  • NNOX N/A
  • EPS
  • VERV N/A
  • NNOX N/A
  • Revenue
  • VERV $24,396,000.00
  • NNOX $10,128,000.00
  • Revenue This Year
  • VERV $84.66
  • NNOX $33.22
  • Revenue Next Year
  • VERV N/A
  • NNOX $236.15
  • P/E Ratio
  • VERV N/A
  • NNOX N/A
  • Revenue Growth
  • VERV 219.91
  • NNOX 5.51
  • 52 Week Low
  • VERV $4.31
  • NNOX $5.26
  • 52 Week High
  • VERV $19.34
  • NNOX $14.28
  • Technical
  • Relative Strength Index (RSI)
  • VERV 32.80
  • NNOX 46.12
  • Support Level
  • VERV $6.02
  • NNOX $5.82
  • Resistance Level
  • VERV $6.68
  • NNOX $7.62
  • Average True Range (ATR)
  • VERV 0.47
  • NNOX 0.40
  • MACD
  • VERV -0.14
  • NNOX 0.02
  • Stochastic Oscillator
  • VERV 0.25
  • NNOX 14.08

About VERV Verve Therapeutics Inc.

Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.

About NNOX NANO-X IMAGING LTD

Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service.

Share on Social Networks: